BackCytomX Therapeutics Overview

CytomX Therapeutics Profit Margin

Profitability ratio analysis for CTMX.

Quarterly Profit Margin

-177.89%
↓ 485.02% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-166.40%
↓ 690.18% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin